BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22514644)

  • 1. Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D.
    Kim TD; Oh S; Shin S; Janknecht R
    PLoS One; 2012; 7(4):e34618. PubMed ID: 22514644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new transgenic mouse line to image chemically induced p53 activation in vivo.
    Briat A; Vassaux G
    Cancer Sci; 2008 Apr; 99(4):683-8. PubMed ID: 18377420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.
    Chin YW; Han SY
    Expert Opin Ther Pat; 2015 Feb; 25(2):135-44. PubMed ID: 25468267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PARP1-dependent recruitment of KDM4D histone demethylase to DNA damage sites promotes double-strand break repair.
    Khoury-Haddad H; Guttmann-Raviv N; Ipenberg I; Huggins D; Jeyasekharan AD; Ayoub N
    Proc Natl Acad Sci U S A; 2014 Feb; 111(7):E728-37. PubMed ID: 24550317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional analysis of JMJD2D reveals molecular basis for site-specific demethylation among JMJD2 demethylases.
    Krishnan S; Trievel RC
    Structure; 2013 Jan; 21(1):98-108. PubMed ID: 23219879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells.
    Berry WL; Janknecht R
    Cancer Res; 2013 May; 73(10):2936-42. PubMed ID: 23644528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of lysine demethylases in DNA damage response: dissecting the recruitment mode of KDM4D/JMJD2D to DNA damage sites.
    Khoury-Haddad H; Nadar-Ponniah PT; Awwad S; Ayoub N
    Cell Cycle; 2015; 14(7):950-8. PubMed ID: 25714495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors.
    Kim TD; Fuchs JR; Schwartz E; Abdelhamid D; Etter J; Berry WL; Li C; Ihnat MA; Li PK; Janknecht R
    Am J Transl Res; 2014; 6(3):236-47. PubMed ID: 24936217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncogenic potential of Jumonji D2 (JMJD2/KDM4) histone demethylase overexpression.
    Young LC; Hendzel MJ
    Biochem Cell Biol; 2013 Dec; 91(6):369-77. PubMed ID: 24219278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rph1/KDM4 mediates nutrient-limitation signaling that leads to the transcriptional induction of autophagy.
    Bernard A; Jin M; González-Rodríguez P; Füllgrabe J; Delorme-Axford E; Backues SK; Joseph B; Klionsky DJ
    Curr Biol; 2015 Mar; 25(5):546-55. PubMed ID: 25660547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone demethylase JMJD2B and JMJD2C induce fibroblast growth factor 2: mediated tumorigenesis of osteosarcoma.
    Li X; Dong S
    Med Oncol; 2015 Mar; 32(3):53. PubMed ID: 25636512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis.
    Van Rechem C; Black JC; Boukhali M; Aryee MJ; Gräslund S; Haas W; Benes CH; Whetstine JR
    Cancer Discov; 2015 Mar; 5(3):255-63. PubMed ID: 25564516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone demethylase Fbxl11/Kdm2a plays an essential role in embryonic development by repressing cell-cycle regulators.
    Kawakami E; Tokunaga A; Ozawa M; Sakamoto R; Yoshida N
    Mech Dev; 2015 Feb; 135():31-42. PubMed ID: 25463925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDM4C (GASC1) lysine demethylase is associated with mitotic chromatin and regulates chromosome segregation during mitosis.
    Kupershmit I; Khoury-Haddad H; Awwad SW; Guttmann-Raviv N; Ayoub N
    Nucleic Acids Res; 2014 Jun; 42(10):6168-82. PubMed ID: 24728997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kdm4b histone demethylase is a DNA damage response protein and confers a survival advantage following γ-irradiation.
    Young LC; McDonald DW; Hendzel MJ
    J Biol Chem; 2013 Jul; 288(29):21376-21388. PubMed ID: 23744078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma.
    Abu-Zaid A; Fang J; Jin H; Singh S; Pichavaram P; Wu Q; Tillman H; Janke L; Rosikiewicz W; Xu B; Van De Velde LA; Guo Y; Li Y; Shendy NAM; Delahunty IM; Rankovic Z; Chen T; Chen X; Freeman KW; Hatley ME; Durbin AD; Murray PJ; Murphy AJ; Thomas PG; Davidoff AM; Yang J
    Cell Rep Med; 2024 Mar; 5(3):101468. PubMed ID: 38508144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging roles of histone demethylases in cancers.
    Tong D; Tang Y; Zhong P
    Cancer Metastasis Rev; 2024 Jun; 43(2):795-821. PubMed ID: 38227150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of the JMJD2B epigenetic regulator differentially affects its ability to coactivate the ETV1 and JUN transcription factors.
    Kim TD; Gu R; Janknecht R
    Int J Biochem Mol Biol; 2023; 14(6):101-115. PubMed ID: 38213775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of the epigenetic JMJD2D protein by SET7/9 promotes prostate tumorigenesis.
    Gu R; Kim TD; Jiang H; Shin S; Oh S; Janknecht R
    Front Oncol; 2023; 13():1295613. PubMed ID: 38045004
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.